?:authorAffiliation
|
-
[\'Doctoral School of Psychology, ELTE, Eötvös Loránd University, Budapest, Hungary.\', \'SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.\', \'Institute of Psychology, ELTE, Eötvös Loránd University, Budapest, Hungary.\', \'Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.\', \'NAP-2-SE New Antidepressant Target Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.\', \'MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary.\', \'SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary. kokonyei.gyongyi@pharma.semmelweis-univ.hu.\', \'Institute of Psychology, ELTE, Eötvös Loránd University, Budapest, Hungary. kokonyei.gyongyi@pharma.semmelweis-univ.hu.\', \'Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary. kokonyei.gyongyi@pharma.semmelweis-univ.hu.\']
|